RecruitingNot ApplicableNCT06319560

Hydroxychloroquine in Type 2 Diabetes During Pregnancy

Hydroxychloroquine as an Adjunct Therapy in the Management of Type 2 Diabetes in Pregnancy: A Randomised Controlled Trial

Sponsor

National University of Malaysia

Enrollment

56 participants

Start Date

Mar 24, 2024

Study Type

INTERVENTIONAL

Conditions

Type 2 Diabetes Diabetes in Pregnancy

Summary

The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main questions it aims to answer are: * Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment

Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether hydroxychloroquine — a medication commonly used for malaria and autoimmune diseases — can help control blood sugar levels in pregnant women who have type 2 diabetes, potentially reducing complications during pregnancy. **You may be eligible if...** - You are pregnant with a single baby - You have a confirmed diagnosis of type 2 diabetes **You may NOT be eligible if...** - You have an autoimmune disease such as lupus or a rheumatic condition - You have chronic kidney disease - Your baby has a known fetal abnormality - You are on steroid therapy - You have diabetic eye disease (retinopathy) - You have thalassemia or are a thalassemia carrier Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.